16
Participants
Start Date
June 7, 2022
Primary Completion Date
October 11, 2024
Study Completion Date
October 11, 2024
Cendakimab
Specified dose on specified days
CYP substrates
Specified dose on specified days
Local Institution - 018, Durham
Local Institution - 002, Inverness
Local Institution - 012, Columbus
Local Institution - 008, Iowa City
Local Institution - 004, Tucson
Local Institution - 001, Los Angeles
Local Institution - 022, San Diego
Local Institution - 016, Bristol
Local Institution - 010, Miami
Local Institution - 021, Plantation
Local Institution - 020, Gurnee
Local Institution - 003, Albuquerque
Lead Sponsor
Celgene
INDUSTRY